SHANGHAI, June 8, 2026 /PRNewswire/ -- Angel Yeast (SH600298), one of the world's leading yeast manufacturers, recently presented its latest research and product developments at the 16th International Feed Congress and Exhibition (TUYEM), with its contributions also highlighted
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
Roquette presenta le novità nei sistemi scalabili di rilascio di farmaci al CPHI China 2026
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China
As Akeso takes center stage at ASCO, China biotech industry cements its coming of age
Il franchising ematologico di base di BeOne Medicines guida la prossima era dell'innovazione oncologica delle cellule B all'EHA 2026
Angel Yeast Showcases Sustainable Protein Innovation at the Growth Asia Summit 2026
Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026
YMTC eyes a Shanghai listing as China boosts semiconductor ambitions, aiming to strengthen domestic chipmaking and reduce foreign…
SHANGHAI, June 4, 2026 /PRNewswire/ -- On June 3, the 19th (2026) International Photovoltaic Power Generation and Smart Energy…
